Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium Respimat in adolescents with moderate persistent asthma
2010-021093-11Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tiotropium in asthma (3 arms), sponsored by Boehringer Ingelheim. Primary endpoint: FEV1 peak0-3 response at Week 24. Started Sep 2010; status: completed.
02
Drugs
tiotropium
03
Conditions
asthma
Beyond the preview
Go deeper on 2010-021093-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021093-11.